Selective Sphingosine 1-Phosphate Receptor Modulators and Other Patient-Care Opportunities in IBD

Monday, December 5, 2022

6:30 AM – 7:30 AM

Location: Northern Hemisphere D

Chair(s)

Stephen B. Hanauer, MD, FACG

Medical Director of Digestive Health Center
Northwestern University Feinberg School of Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Speaker(s)

Bincy P. Abraham, MD, MS, FACG

Professor of Clinical Medicine
Houston Methodist Hospital, Weill Cornell Medical College; Texas A&M University College of Medicine
Houston, Texas
Uma Mahadevan, MD

Professor of Medicine
University of California, San Francisco
San Francisco, California

This session is supported by an independent educational grant from Bristol Myers Squibb.

6:30 AM Introduction and Pre-Activity Survey
Stephen B. Hanauer, MD

6:35 AM Role of Sphingosine 1 Phosphate Modulators in Ulcerative Colitis
Stephen B. Hanauer, MD

6:50 AM Role of S1P Leukocyte Trafficking in IBD and Positioning
Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE

7:05 AM Patient-Care Strategies
Uma Mahadevan, MD

7:20 AM Panel Discussion Q&A and Post-Activity Survey
Stephen B. Hanauer, MD; Bincy P. Abraham, MD, MS, AGAF, FACG, FASGE; Uma Mahadevan, MD

Learning Objectives:

Describe the mechanism of action of S1P receptor modulators
Evaluate efficacy and safety data associated with current and emerging S1P receptor modulator drugs
Implement key patient-care strategies, including shared decision-making, into clinical practice for IBD